MAPT and type 2 diabetes mellitus: Clinical studies involving 114 patients with T2DM suggested that the combination of NSE and P-tau in serum exosomes, which predicts the AUC of cognitive impairment in patients with T2DM, was 0.827 (Domínguez et al., 2014).